• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Hamilton Health Sciences - Developmental Therapeutics Review - Q1 2011 Product Image

Hamilton Health Sciences - Developmental Therapeutics Review - Q1 2011

  • Published: March 2011
  • 58 pages
  • Global Markets Direct

Hamilton Health Sciences – Developmental Therapeutics Review – Q1 2011

Summary

Global Market Direct’s pharmaceuticals report, “Hamilton Health Sciences – Developmental Therapeutics Review – Q1 2011” provides data on the institute’s research and development focus. The report includes information on therapeutics under development, complete with latest updates, and features on discontinued projects (if applicable).
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, institute’s website, and featured press releases, both from institute and industry-specific third party sources, put together by Global Markets Direct’s team of industry experts.

Scope

- Review of therapeutics under development by Hamilton Health Sciences.
- Overview of products under development across various therapy areas.
- Coverage of therapeutic molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Hamilton Health Sciences with complete READ MORE >



List of Tables
List of Figures
Hamilton Health Sciences Snapshot
Hamilton Health Sciences Overview
Key Information
Key Facts
Hamilton Health Sciences – Research and Development Overview
Key Therapeutic Areas
Hamilton Health Sciences – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pipeline Products – Combination Treatment Modalities
Hamilton Health Sciences – Pipeline Products Glance
Hamilton Health Sciences – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
Hamilton Health Sciences Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Hamilton Health Sciences – Drug Profiles
Acetyl Salicylic Acid
Product Description
Mechanism of Action
R&D Progress
Atenolol
Product Description
Mechanism of Action
R&D Progress
Bosentan
Product Description
Mechanism of Action
R&D Progress
Budesonide + Montelukast
Product Description
Mechanism of Action
R&D Progress
Ciclesonide
Product Description
Mechanism of Action
R&D Progress
Clonidine
Product Description
Mechanism of Action
R&D Progress
Clonidine + Acetyl Salicylic Acid
Product Description
Mechanism of Action
R&D Progress
Desvenlafaxine Succinate
Product Description
Mechanism of Action
R&D Progress
Doxycycline
Product Description
Mechanism of Action
R&D Progress
Doxycycline + Rifampicin
Product Description
Mechanism of Action
R&D Progress
Hypotonic Parenteral Fluid (Hamilton Health Sciences)
Product Description
Mechanism of Action
R&D Progress
Isotonic Parenteral Fluid (Hamilton Health Sciences)
Product Description
Mechanism of Action
R&D Progress
Methylprednisolone
Product Description
Mechanism of Action
R&D Progress
Metronidazole
Product Description
Mechanism of Action
R&D Progress
Montelukast
Product Description
Mechanism of Action
R&D Progress
Paroxetine
Product Description
Mechanism of Action
R&D Progress
Rifampin
Product Description
Mechanism of Action
R&D Progress
Telmisartan
Product Description
Mechanism of Action
R&D Progress
Unfractionated heparin
Product Description
Mechanism of Action
R&D Progress
Autologous Dendritic Cells + Tn-MUC1 Peptide
Product Description
Mechanism of Action
R&D Progress
bupivicaine
Product Description
Mechanism of Action
R&D Progress
DC-Tn-MUC1
Product Description
Mechanism of Action
R&D Progress
Domperidone for Gynecological Disorders (Hamilton Health Sciences)
Product Description
Mechanism of Action
R&D Progress
Human recombinant growth hormone
Product Description
Mechanism of Action
R&D Progress
Rituxan
Product Description
Mechanism of Action
R&D Progress
Tiotropium
Product Description
Mechanism of Action
R&D Progress
Hamilton Health Sciences – Pipeline Analysis
Hamilton Health Sciences – Pipeline Products by Therapeutic Class
Hamilton Health Sciences - Pipeline Products By Target
Hamilton Health Sciences – Pipeline Products by Route of Administration
Hamilton Health Sciences – Pipeline Products by Molecule Type
Hamilton Health Sciences - Dormant Projects
Hamilton Health Sciences – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos